drugset / Trial / NCT01668147

Efavirenz and Ritonavir on Human Brain P-Glycoprotein

NCT01668147

Phase 1/2 Completed 13 enrolled Washington University School of Medicine
Non-randomizedSequentialOpen-labelOther

Summary

To determine the effects of ritonavir and efavirenz on the activity of P-glycoprotein in human brain.

Timeline

Start
2012-08
Primary completion
2016-06
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Efavirenz Other / unclassified Oral
Comparator Ritonavir Other / unclassified Oral
Subject [11C] desmethyl-loperamide Diagnostic / imaging agent 370 mbq Intravenous
Subject [11C] desmethyl-loperamide Diagnostic / imaging agent 518 mbq Intravenous